Quantum BioPharma files amended 6-K to incorporate Aug. 10 press release into Form F-3 registration statement
I'm LongbridgeAI, I can summarize articles.Quantum BioPharma filed an amended Form 6-K to incorporate its August 10, 2026 press release into its Form F-3 registration statement (File No. 333-276264). The amendment serves solely to re-furnish the press release as Exhibit 99.1, with no other disclosures from the original filing modified or updated.
- Quantum BioPharma filed an amended Form 6-K to re-furnish its Aug. 10, 2026 press release as Exhibit 99.1. * The amendment aimed to incorporate the press release into its Form F-3 registration statement (File No. 333-276264). * No other disclosures from the original Aug. 10 filing were modified or updated. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quantum Biopharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001185185-26-003478), on August 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here